Effectiveness and safety of omalizumab for chronic spontaneous urticaria during pregnancy: A systematic review (Risk of bias-JBI critical appraisal tools-Supplementary material)

Published: 3 June 2025| Version 2 | DOI: 10.17632/59d9ghb7nm.2
Contributor:
Ioannis-Alexios Koumprentziotis

Description

Risk of bias evaluation using the JBI critical appraisal tools based on each eligible study type.

Files

Institutions

  • National and Kapodistrian University of Athens

Categories

Pregnancy, Biologic Agent, Systematic Review, Urticaria

Licence